Gland Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 28, 2025
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has sent out the notice for its 47th Annual General Meeting (AGM) scheduled for Thursday, August 28, 2025 at 11:00 AM via video conferencing. Key items on the agenda include adoption of audited standalone and consolidated financial statements for FY2024-25, declaration of a final dividend of ₹18 per equity share on a face value of ₹1 (record date August 14, 2025), and reappointment of two retiring directors - Dr. Jia Ai Zhang and Mr. Srinivas Sadu (Executive Chairman). Additionally, members will vote on appointing M/s. RVR & Associates as Secretarial Auditors for a 5-year term and reappointing Mr. Essaji Goolam Vahanvati as Independent Director for a second term of 5 years starting September 30, 2025, along with a proposed commission of 0.1% of audited net profits capped at ₹25 lakh per annum. E-voting is open from August 25 to August 27, 2025.
Shareholders of record as of August 14, 2025 will receive a final dividend of ₹18 per share. The director reappointments and auditor appointment are routine governance items and unlikely to materially affect the stock. Investors should review the annual report for FY2024-25 financial performance details.